Position in ASND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$350,035,811
+$15,193,569 QoQ
Shares Held
1,530,345
-2.5% QoQ
Ownership
2.33%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.63341599443262.ToString("F0")%
Shared 0.ToString("F0")%
None 0.36658400556737203.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. ASND ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
This page
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in ASND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $350,035,811 | 1,530,345 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $334,842,242 | 1,570,260 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $343,191,388 | 1,726,228 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $323,709,746 | 1,875,491 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $351,636,057 | 2,256,102 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $314,329,107 | 2,283,207 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $316,705,621 | 2,121,128 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $243,322,104 | 1,784,148 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $269,373,753 | 1,781,926 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $181,991,452 | 1,444,950 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $153,368,086 | 1,637,848 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $183,601,887 | 2,057,164 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $361,325,288 | 3,369,943 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $453,082,881 | 3,709,841 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $400,118,353 | 3,874,863 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $480,173,260 | 5,165,375 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $571,560,921 | 4,870,151 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $640,523,294 | 4,761,193 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $770,764,454 | 4,835,714 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $665,807,963 | 5,061,254 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $653,851,543 | 5,073,336 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,103,923,824 | 6,619,042 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,045,924,633 | 6,777,635 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,044,822,393 | 7,064,384 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $809,984,473 | 7,192,829 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||